The first Japanese biobank of patient‐derived pediatric acute lymphoblastic leukemia xenograft models-Reference-Cited by-同舟云学术

The first Japanese biobank of patient‐derived pediatric acute lymphoblastic leukemia xenograft models

Published:2022-08-30 Issue:11 Volume:113 Page:3814-3825
ISSN:1347-9032
Container-title:Cancer Science
language:en
Short-container-title:Cancer Science

Author:

Tanaka Kuniaki¹,Kato Itaru¹²^ORCID,Dobashi Yuu³,Imai Jun‐ichi³,Mikami Takashi¹,Kubota Hirohito¹,Ueno Hiroo¹⁴,Ito Mamoru⁵,Ogawa Seishi⁴,Nakahata Tatsutoshi⁵⁶,Takita Junko¹,Toyoda Hidemi²⁷,Ogawa Chitose²⁸,Adachi Souichi⁹,Watanabe Shinya³,Goto Hiroaki²¹⁰

Affiliation:

1. Department of Pediatrics Graduate School of Medicine Kyoto University Kyoto Japan

2. Japan Children's Cancer Group Relapsed ALL Committee Nagoya Japan

3. Medical‐Industrial Translational Research Center Fukushima Medical University Fukushima Japan

4. Department of Pathology and Tumor Biology Kyoto University Graduate School of Medicine Kyoto Japan

5. Central Institute for Experimental Animals Kawasaki Japan

6. Department of Fundamental Cell Technology Center for iPS Cell Research and Application Kyoto University Kyoto Japan

7. Department of Pediatrics Mie University Graduate School of Medicine Mie Japan

8. Department of Pediatric Oncology National Cancer Center Hospital Tokyo Japan

9. Department of Human Health Sciences Graduate School of Medicine Kyoto University Kyoto Japan

10. Division of Hematology/Oncology Kanagawa Children's Medical Center Yokohama Japan

Funder

Takeda Science Foundation

Publisher

Wiley

Subject

Cancer Research,Oncology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cas.15506

Reference42 articles.

1. Factors influencing survival after relapse from acute lymphoblastic leukemia: a Children's Oncology Group study

2. Improved outcome for children with acute lymphoblastic leukemia: results of Total Therapy Study XIIIB at St Jude Children's Research Hospital

3. High-throughput screening using patient-derived tumor xenografts to predict clinical trial drug response

4. Patient-derived xenografts as tools in pharmaceutical development

5. A review of new agents evaluated against pediatric acute lymphoblastic leukemia by the Pediatric Preclinical Testing Program

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Orthotopic and metastatic tumour models in preclinical cancer research;Pharmacology & Therapeutics;2024-05

2. Modeling the Tumor Microenvironment and Cancer Immunotherapy in Next-Generation Humanized Mice;Cancers;2023-05-30

3. Patient-derived xenograft models in cancer therapy: technologies and applications;Signal Transduction and Targeted Therapy;2023-04-12

4. Appropriate Means to Vulgarize the Human Cytogenetics;Open Journal of Genetics;2023